|
Q3 FY2026
As of Sep 26, 2026
|
Q2 FY2026
As of Jun 27, 2026
|
Q1 FY2026
As of Mar 28, 2026
|
Q4 FY2025
As of Dec 27, 2025
|
Q3 FY2025
As of Sep 27, 2025
|
Q2 FY2025
As of Jun 28, 2025
|
Q1 FY2025
As of Mar 29, 2025
|
Q4 FY2024
As of Dec 28, 2024
|
Q3 FY2024
As of Sep 28, 2024
|
Q2 FY2024
As of Jun 29, 2024
|
Q1 FY2024
As of Mar 30, 2024
|
Q4 FY2023
As of Dec 30, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jul 1, 2023
|
Q1 FY2023
As of Apr 1, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 24, 2022
|
Q2 FY2022
As of Jun 25, 2022
|
Q1 FY2022
As of Mar 26, 2022
|
Q4 FY2021
As of Dec 25, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other Receivables | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Acquisition-related intangibles, net | ||||||||||||||||||||
| Investment: equity method | ||||||||||||||||||||
| ATMP JV | ||||||||||||||||||||
| Total investment: equity method | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accounts Payable, Other | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Current portion of long-term debt, net | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Joint Venture | ||||||||||||||||||||
| Total other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Capital stock: | ||||||||||||||||||||
| Common stock, par value $0.01; shares authorized: 4,000; shares issued: 1,640 and 1,695; shares outstanding: 1,640 and 1,630 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock (shares) | ||||||||||||||||||||
| Treasury stock, at cost (shares held: — and 65) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
| Common stock, outstanding (in shares) | ||||||||||||||||||||
| Common stock, authorized (in shares) | ||||||||||||||||||||
| Common stock, issued (in shares) | ||||||||||||||||||||
| Common stock, par value (in dollars per share) | ||||||||||||||||||||
Loading...